Technology companies are rapidly investing in AI capabilities, and last week, a groundbreaking partnership was announced between Oracle Health, Cleveland Clinic, and G42, a cloud computing and AI development company based in the United Arab Emirates. The collaboration aims to co-develop and launch an AI-based healthcare analytics and clinical intelligence platform by 2025.
The platform’s primary objectives include providing population-level health data for systemic analyses, understanding and driving cost reductions for health interventions, empowering clinicians to make better care decisions through AI, and personalizing treatments to improve diagnostic capabilities. Additionally, the platform will promote better life sciences research by identifying clinical trial candidates.
Oracle Health, known for its enterprise-grade software solutions and data warehousing capabilities, has made significant strides in the healthcare sector, particularly after acquiring Cerner in 2021. Cleveland Clinic, a renowned institution for cutting-edge clinical research and care delivery, will contribute its expertise in clinical care models to the partnership. Meanwhile, G42, an Emirati AI company with investments in various sectors, including healthcare, brings its AI capabilities to the table.
The collaboration of these three powerhouses signals a promising future for the healthcare industry. Larry Ellison, executive chairman and CTO of Oracle, emphasized the need to rethink care delivery in the face of a complex healthcare landscape. Morton C. Mandel, CEO of Cleveland Clinic, highlighted the potential of AI-enabled care models to positively impact global health systems.
This partnership is part of a larger trend of significant AI investments, including President Trump’s recent tour of the Middle East, which resulted in a $1.4 trillion commitment from the UAE to support U.S. AI infrastructure and data centers. As more details about the partnership emerge, the combined expertise of Oracle Health, Cleveland Clinic, and G42 is expected to drive meaningful improvements in health outcomes on a global scale.
